DENOSUMAB (Xgeva®)

Clinical Indication

Prevention of skeletal related events in adults with bone metastases from solid tumours other than prostate

Comments

Red for patients with severe renal impairment (creatinine clearance less than 30ml/min)

Date of classification

May 2015

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.